SCHEMBL19406563

SCHEMBL19406563

CCCCCCCCCCCCCCc1c(C(=O)O)c(CCCCCCCCCCCCCC)c(C(=O)O)c(CCCCCCCCCCCCCC)c1C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BID P55957 3/20 0.51
MCL1 Q07820 3/20 0.51
KAT8 Q9H7Z6 3/20 0.51
PPARA Q07869 3/20 0.51
BCL2L1 Q07817 2/20 0.51
BAK1 Q16611 2/20 0.51
PPARG P37231 2/20 0.51
EP300 Q09472 2/20 0.51
KAT5 Q92993 2/20 0.51
KAT2A Q92830 1/20 0.51
KAT2B Q92831 1/20 0.51
SAE1 Q9UBE0 1/20 0.51
SCD O00767 1/20 0.47
GPR35 Q9HC97 5/20 0.46
RARB P10826 4/20 0.46
MEN1 O00255 1/20 0.46
ALDH1A1 P00352 1/20 0.46
RARA P10276 1/20 0.46
MAPT P10636 1/20 0.46
MTOR P42345 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14989154 1.00 BID (0.51) BIDMCL1KAT8PPARABCL2L1
SCHEMBL19406558 1.00 BID (0.51) BIDMCL1KAT8PPARABCL2L1
SCHEMBL14989291 1.00 BID (0.51) BIDMCL1KAT8PPARABCL2L1
SCHEMBL14989267 1.00 BID (0.51) BIDMCL1KAT8PPARABCL2L1
SCHEMBL19406556 1.00 BID (0.51) BIDMCL1KAT8PPARABCL2L1
SCHEMBL14989230 1.00 BID (0.51) BIDMCL1KAT8PPARABCL2L1
SCHEMBL14989057 1.00 BID (0.51) BIDMCL1KAT8PPARABCL2L1
SCHEMBL14989170 1.00 BID (0.51) BIDMCL1KAT8PPARABCL2L1
SCHEMBL17798912 0.96 BID (0.49) BIDMCL1KAT8PPARABCL2L1
SCHEMBL9718193 0.96 BID (0.49) BIDMCL1KAT8PPARABCL2L1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10308042-B2 Radiation-curable inkjet ink composition OCÉ HOLDING B. V. (NL) 2019-06-04 US disclosed
EP-3225666-B1 RADIATION-CURABLE INKJET INK COMPOSITION OCE HOLDING BV (NL) 2019-01-30 EP disclosed
US-20170283640-A1 RADIATION-CURABLE INKJET INK COMPOSITION Océ Holding B.V. (NL) 2017-10-05 US disclosed
EP-3225666-A1 RADIATION-CURABLE INKJET INK COMPOSITION OCE Holding B.V. (NL) 2017-10-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10308042-B2 Radiation-curable inkjet ink composition BCCIP, IQGAP1, RHOC BID 4772/4885MCL1 2933/4885KAT8 1230/4885
US-20170283640-A1 RADIATION-CURABLE INKJET INK COMPOSITION BCCIP, IQGAP1, RHOC BID 4777/4885MCL1 2928/4885KAT8 1168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.